The idea of RIAT was born in a specific time period: the early part of this decade. This was when we started realising that clinical trials published in traditional biomedical journals were in the best case scenario extreme summaries of clinical study reports and other documents which contained extensive descriptions of the design, conduct and results. The underlying richness of detail and data, which was astonishing for those who had been used to journal articles, allowed two important aspects of scrutiny. First, we could do many more analyses and look at traditionally neglected aspects, such as harms reporting. This was not possible with journal articles. Second, we and other groups started noticing what we called discrepancies between the content of clinical study reports and their published counterparts. The discrepancies were misreporting in most cases.
Full article here (English only).